logo image
search icon
Global Therapeutic Proteins and Oral Vaccines Market

Therapeutic Proteins and Oral Vaccines Market Size, Share & Trends Analysis Report By Drug Class, By Distribution Channel, By Application (Oncology, Hematology, Immunology, Endocrinology, Infectious Disease, Cardiovascular Disease, Other Applications), By Region, And By Segment Forecasts, 2024-2031

Report ID : 1037 | Published : 2024-05-30 | Pages: 180 | Format: PDF/EXCEL

The Therapeutic Proteins and Oral Vaccines Market Size is valued at 239.91 Million in 2023 and is predicted to reach 436.26 Million by the year 2031 at a 8.1 % CAGR during the forecast period for 2024-2031.

Key Industry Insights & Findings from the Report:

  • The rise in severe diseases such as cancer, diabetes, and autoimmune disorders has increased the demand for therapeutic proteins. These proteins are used for treating conditions where traditional small-molecule drugs are ineffective.
  • There is a growing awareness between both healthcare professionals and the general public about the benefits of therapeutic proteins and vaccines in preventing and treating diseases. This increased awareness is driving demand for these products.
  • North America dominated the market and accounted for a global revenue share in 2023.
  • The manufacturing of therapeutic proteins and oral vaccines often involves complex processes, such as cell culture, purification, and formulation. Ensuring consistent product quality and scalability can be challenging, leading to production delays and cost overruns.

therapeutic protein

Therapeutic proteins are genetically engineered proteins that have a wide range of treatment applications. Therapeutic proteins are mainly prepared for pharmaceutical use. Oral vaccines are biologically prepared products, which are used in treating or preventing various infectious diseases. The increasing number of pharmaceutical drug developments or innovations is expected to drive the growth of the therapeutic protein and oral vaccine market in the near future.

Major driving factors of the therapeutic proteins and oral vaccines market are the increasing need for therapeutic proteins and oral vaccines, high prevalence of cancer diseases, rising number of clinical trials, increasing investments by key players for the development of promising therapies. Furthermore, advanced medical technologies, growth in the population, and a growing number of health-conscious people are enhancing the growth of the therapeutic proteins and oral vaccines market. However, the high price of devices, complex procedures, lack of strict government laws are restraining the growth of this market.

Competitive Landscape

Some Major Key Players In The Therapeutic Proteins and Oral Vaccines Market:

  • Abbott Laboratories,
  • Amgen, Inc.,
  • Biogen, Inc.,
  • Eily, Lilly, and Company,
  • Hoffmann-La Roche,
  • Johnson and Johnson,
  • Merck & Co.,
  • Novo Nordisk,
  • Pfizer, Inc.,
  • Sanofi S.A.,
  • Serum Institute of India Pvt. Ltd.,
  • Emergent Biosolutions Inc.,
  • TransAlgae,
  • MigVax Ltd,
  • Lumen Bioscience, Inc.,

Market Segmentation

The therapeutic proteins and oral vaccines market is segmented into Drug Class, Distribution Channels, Applications, and regions. The Drug Class segment is further bifurcated into Therapeutic Proteins and Oral Vaccines. Therapeutic Proteins are subdivided into Therapeutic Proteins, Growth Factors, Fusion Proteins, Monoclonal Antibodies, Hormones, Coagulation Factors, and Other Therapeutic Proteins. While, Oral Vaccines are subdivided into Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine, and Other Oral Vaccines. In the coming future, therapeutic proteins will be in high scope due to their effective and fast results and rise in therapy innovations. By Distribution Channels, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Hospital Pharmacies will upscale the market of therapeutic proteins and oral vaccines over the forecast period. In terms of Applications, the market can be divided into Oncology, Hematology, Immunology, Endocrinology, Infectious Disease, Cardiovascular Disease, and Other Applications. Oncology and Infectious diseases are the fastest-growing segments of this market due to the increasing prevalence of cancer and infectious diseases. Based on the region, the therapeutic proteins and oral vaccines market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America followed by Europe holds the maximum share of this market due to increased research and development expenditure, presence of significant market players and fast adaption of advanced technologies.

Recent Developments:

  • In April 2024, Bharat Biotech along with Bilthoven Biologicals B.V. (BBio), a fully owned subsidiary of Serum Institute of India Pvt. Ltd. with headquarters in the Netherlands, announced a partnership to enhance the production and supply security of oral polio vaccines (OPV).By means of this partnership, BBIL and BBio shall acquire collectively the necessary regulatory approvals and licenses to manufacture OPVs for global distribution in India from medicinal substances produced at Bilthoven Biologicals in the Netherlands.

Therapeutic Proteins and Oral Vaccines Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 239.91 Million

Revenue Forecast In 2031

USD 436.26 Million

Growth Rate CAGR

CAGR of 8.1 % from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Drug Class, By Distribution Channel, By Application

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Abbott Laboratories, Amgen, Inc., Biogen, Inc., Eily, Lilly, and Company, F. Hoffmann-La Roche, Johnson and Johnson, Merck & Co., Novo Nordisk, Pfizer, Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., Emergent Biosolutions Inc., TransAlgae, MigVax Ltd, Lumen Bioscience, Inc., and Other Prominent Players.

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Therapeutic Proteins and Oral Vaccines Market Snapshot

Chapter 4. Global Therapeutic Proteins and Oral Vaccines Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Drug Class, Estimates & Trend Analysis

5.1. By Drug Class, & Market Share, 2019 & 2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Drug Class:

5.2.1. Therapeutic Proteins

5.2.1.1.  Growth Factors

5.2.1.2.  Fusion Proteins

5.2.1.3.  Monoclonal Antibodies

5.2.1.4.  Hormones

5.2.1.5.  Coagulation Factors

5.2.1.6.  Other Therapeutic Proteins

5.2.2. Oral Vaccines

5.2.2.1.  Live Attenuated Vaccine

5.2.2.2.  Inactivated Vaccine

5.2.2.3.  Recombinant Vaccine

5.2.2.4.  Other Oral Vaccines

Chapter 6. Market Segmentation 1: By Distribution Channels Estimates & Trend Analysis

6.1. By Distribution Channels & Market Share, 2019 & 2031

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Distribution Channels:

6.2.1. Hospital Pharmacies

6.2.2. Retail Pharmacies

6.2.3. Online Pharmacies

Chapter 7. Market Segmentation 1: By Applications Estimates & Trend Analysis

7.1. By Applications & Market Share, 2019 & 2031

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Applications:

7.2.1. Oncology

7.2.2. Hematology

7.2.3. Immunology

7.2.4. Endocrinology

7.2.5. Infectious Disease

7.2.6. Cardiovascular Disease

7.2.7. Other Applications

Chapter 8. Therapeutic Proteins and Oral Vaccines Market Segmentation 3: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) estimates and forecasts By Drug Class, 2024-2031

8.1.2. North America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) estimates and forecasts By Distribution Channels, 2024-2031

8.1.3. North America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) estimates and forecasts By Applications, 2024-2031

8.1.4. North America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) estimates and forecasts by country, 2024-2031

8.2. Europe

8.2.1. Europe Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Drug Class, 2024-2031

8.2.2. Europe Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Distribution Channels, 2024-2031

8.2.3. Europe Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Applications, 2024-2031

8.2.4. Europe Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) by country, 2024-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Drug Class, 2024-2031

8.3.2. Asia Pacific Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Distribution Channels, 2024-2031

8.3.3. Asia Pacific Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Applications, 2024-2031

8.3.4. Asia Pacific Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) by country, 2024-2031

8.4. Latin America

8.4.1. Latin America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Drug Class, (US$ Million) 2024-2031

8.4.2. Latin America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Distribution Channels, (US$ Million) 2024-2031

8.4.3. Latin America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Applications, (US$ Million) 2024-2031

8.4.4. Latin America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) by country, (US$ Million) 2024-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Drug Class, (US$ Million) 2024-2031

8.5.2. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Distribution Channels, (US$ Million) 2024-2031

8.5.3. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Applications, (US$ Million) 2024-2031

8.5.4. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) by country, (US$ Million) 2024-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Abbott Laboratories

9.2.2. Amgen, Inc.

9.2.3. Biogen, Inc.

9.2.4. Eily, Lilly, and Company

9.2.5. F. Hoffmann-La Roche

9.2.6. Johnson and Johnson

9.2.7. Merck & Co.

9.2.8. Novo Nordisk

9.2.9. Pfizer, Inc.

9.2.10. Sanofi S.A.

9.2.11. Serum Institute of India Pvt. Ltd.

9.2.12. Emergent Biosolutions Inc.

9.2.13. TransAlgae

9.2.14. MigVax Ltd

9.2.15. Lumen Bioscience, Inc.

9.2.16. Neurelis, Inc.

9.2.17. Other Prominent Player

Global Therapeutic Proteins and Oral Vaccines Market Segmentation

Global Therapeutic Proteins and Oral Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Drug Class

  • Therapeutic Proteins
  • Growth Factors
  • Fusion Proteins
  • Monoclonal Antibodies
  • Hormones
  • Coagulation Factors
  • Other Therapeutic Proteins
  • Oral Vaccines
  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • Recombinant Vaccine
  • Other Oral Vaccines

therapeutic protein

Global Therapeutic Proteins and Oral Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Distribution Channels

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Therapeutic Proteins and Oral Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Applications

  • Oncology
  • Hematology
  • Immunology
  • Endocrinology
  • Infectious Disease
  • Cardiovascular Disease
  • Other Applications

Global Therapeutic Proteins and Oral Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country,

  • U.S.
  • Canada

Europe Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country,

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country, 

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country, 

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country, 

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Therapeutic Proteins and Oral Vaccines Market Size?

The Therapeutic Proteins and Oral Vaccines Market is expected to grow at an 8.1 % CAGR during the forecast period for 2024-2031.

Abbott Laboratories, Amgen, Inc., Biogen, Inc., Eily, Lilly, and Company, F. Hoffmann-La Roche, Johnson and Johnson, Merck & Co., Novo Nordisk, Pfizer

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$3786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach